These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 10528831)

  • 41. Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium.
    Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M
    Gynecol Oncol; 2001 May; 81(2):178-83. PubMed ID: 11330946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Proliferative activity of normal endometrial cells, endometrial hyperplasia cells and endometrial cancer cells using the monoclonal antibody to PCNA].
    Hareyama H
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1427-1. PubMed ID: 7705752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma.
    Götte M; Wolf M; Staebler A; Buchweitz O; Kelsch R; Schüring AN; Kiesel L
    J Pathol; 2008 Jul; 215(3):317-29. PubMed ID: 18473332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of cold-inducible RNA-binding protein in the normal endometrium, endometrial hyperplasia, and endometrial carcinoma.
    Hamid AA; Mandai M; Fujita J; Nanbu K; Kariya M; Kusakari T; Fukuhara K; Fujii S
    Int J Gynecol Pathol; 2003 Jul; 22(3):240-7. PubMed ID: 12819390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
    Afify AM; Craig S; Paulino AF; Stern R
    Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liquid-based endometrial cytology: cyto-histological correlation in a population of 917 women.
    Buccoliero AM; Gheri CF; Castiglione F; Garbini F; Barbetti A; Fambrini M; Bargelli G; Pappalardo S; Taddei A; Boddi V; Scarselli GF; Marchionni M; Taddei GL
    Cytopathology; 2007 Aug; 18(4):241-9. PubMed ID: 17559564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26.
    Pilka R; Domanski H; Hansson S; Eriksson P; Casslén B
    Mol Hum Reprod; 2004 Sep; 10(9):641-50. PubMed ID: 15273280
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ki-67, Bcl-2 and p53 expression in endometrial polyps and in the normal endometrium during the menstrual cycle.
    Maia H; Maltez A; Studart E; Athayde C; Coutinho EM
    BJOG; 2004 Nov; 111(11):1242-7. PubMed ID: 15521869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of benign endometrial cells in Pap smears from postmenopausal women.
    Wu HH; Schuetz MJ; Cramer H
    J Reprod Med; 2001 Sep; 46(9):795-8. PubMed ID: 11584479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Bax gene expression in endometrial carcinoma].
    Chao H; Sun J; Lu S
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):214-6. PubMed ID: 11783089
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Bcl-2 gene expression in endometrial carcinoma].
    Sheng X; Song H; He X
    Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):365-6. PubMed ID: 10921033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Surgical treatment of precancer and cancer of endometrium].
    Ivanov S; Khadzhiolov N; Batashki I
    Akush Ginekol (Sofiia); 2007; 46(6):12-4. PubMed ID: 17974165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endometrial hyperplasia and carcinoma in endometrial polyps: clinicopathologic and follow-up findings.
    Mittal K; Da Costa D
    Int J Gynecol Pathol; 2008 Jan; 27(1):45-8. PubMed ID: 18156974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics.
    McKenney JK; Longacre TA
    Adv Anat Pathol; 2009 Jan; 16(1):1-22. PubMed ID: 19098463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxidative stress in endometrial hyperplasia.
    Gómez-Zubeldia MA; Bazo AP; Gabarre JJ; Nogales AG; Palomino JC
    Menopause; 2008; 15(2):363-8. PubMed ID: 17893631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The ability of endometrial biopsies with atypical complex hyperplasia to guide surgical management.
    Miller C; Bidus MA; Pulcini JP; Maxwell GL; Cosin JA; Rose GS
    Am J Obstet Gynecol; 2008 Jul; 199(1):69.e1-4. PubMed ID: 18241812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Atypical endometrial hyperplasia: characteristics of histopathological diagnosis in curettings].
    Roa JC; Chuaqui R; Le Cerf P
    Rev Chil Obstet Ginecol; 1993; 58(5):388-92. PubMed ID: 7991860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ghrelin expression of endometrium hyperplasia and endometrioid carcinoma.
    Dagli AF; Aydin S; Kocdor H; Gurates B; Sahin I; Catak Z; Ozercan MR; Ozercan IH
    Gynecol Endocrinol; 2011 Mar; 27(3):199-204. PubMed ID: 20712427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.